Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential

dc.contributor.authorInthanon K.
dc.contributor.authorWong-a-nan N.
dc.contributor.authorDheeranupattana S.
dc.contributor.authorGuerra A.G.
dc.contributor.authorDavies N.M.
dc.contributor.authorKesornpun C.
dc.contributor.authorSangher S.
dc.contributor.authorKittakoop P.
dc.contributor.correspondenceInthanon K.
dc.contributor.otherMahidol University
dc.date.accessioned2025-02-24T18:12:59Z
dc.date.available2025-02-24T18:12:59Z
dc.date.issued2025-02-03
dc.description.abstractObesity poses a significant global health challenge, necessitating the search for novel therapeutic agents to address this epidemic. Chromenes, known for their diverse bioactivities, hold promise as potential anti-obesity compounds, yet research in this area remains limited. This pioneering study represents the first exploration of synthetic chromenes as potential anti-obesity agents, unveiling the underlying molecular pathways governing adipogenesis and lipolysis. Twenty-nine chromenes were synthesized using green chemistry approaches, resulting in five novel compounds: 1, 2, 3, 4, and 5. Among them, 14 chromenes demonstrated a lack of toxicity to pre-adipocytes (PAs) and mature adipocytes (MAs) of 3T3-L1 cells. The anti-adipogenesis and lipolysis enhancement potential of these non-toxic 14 chromenes were comprehensively evaluated using Oil Red O staining technique, LDH activity measurement, and glycerol release assays. Notably, 4, 5, 21 and 25 exhibited remarkable efficacy in reducing intracellular lipid accumulation without inducing cellular stress or cell death. Molecular analysis revealed significant alterations in the expression of key transcription factors involved in adipogenesis and lipid metabolism, including PPARγ, C/EBPα, ADD-1, Pref-1, IRS-1, GLUT-4, adiponectin, FAS, aP2, ATGL, and HSL. This suggests their potential role in anti-adipogenesis. Additionally, the treatments with 4 and 25 showed potential for enhancing lipolysis, providing further evidence of their anti-obesity properties. This study presents several promising prospects for the development of synthetic chromenes as potential anti-obesity agents, opening new avenues for drug discovery and benefitting individuals worldwide in addressing obesity-related challenges to human health. In addition, predictive in silico modeling was performed on the identified candidate chromenes. This modeling provides prospective anti-HIV activity, pharmacokinetic, metabolism, and permeability data, setting the groundwork for further investigation into these potential new chemical entities.
dc.identifier.citationScientific reports Vol.15 No.1 (2025) , 4051
dc.identifier.doi10.1038/s41598-025-87945-1
dc.identifier.eissn20452322
dc.identifier.pmid39900791
dc.identifier.scopus2-s2.0-85217848813
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/105392
dc.rights.holderSCOPUS
dc.subjectMultidisciplinary
dc.titleRegulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85217848813&origin=inward
oaire.citation.issue1
oaire.citation.titleScientific reports
oaire.citation.volume15
oairecerif.author.affiliationChulabhorn Graduate Institute
oairecerif.author.affiliationChulabhorn Research Institute
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationFaculty of Science and Engineering
oairecerif.author.affiliationUniversity of Alberta
oairecerif.author.affiliationThammasat University
oairecerif.author.affiliationMinistry of Higher Education, Science, Research and Innovation
oairecerif.author.affiliationChiang Mai University

Files

Collections